PUNE, India, June 23, 2017 /PRNewswire/ --
According to a new market research report "Needles Market by Type (Conventional (Bevel, Vented) & Safety), Product (Suture, Blood Collection, Insufflation), Material (Stainless Steel, Plastic), Delivery Mode (IV, IM, Hypodermic), End-User (Hospitals, Diagnostic Centers) - Global Forecast to 2022" published by MarketsandMarkets™, the Market is expected to reach USD 8.47 Billion by 2022, at CAGR of 7.8% during the forecast period.
Browse 92 market data tables and 46 figures spread through 167 pages and in-depth TOC on "Needles Market"
Early buyers will receive 10% customization on this report
This report studies the global Needles Market over the forecast period of 2017 to 2022. Key factors such growing geriatric population, increasing number of hospitals in emerging markets, and high prevalence of chronic diseases is the major factors driving the growth of the Needles Market across the globe.
By type, the conventional needles segment is expected to hold the largest market share in 2017
On the basis of type, the global Needles Market is segmented into two broad categories, namely, conventional needles and safety needles. The conventional Needles Market is estimated to command the larger share of the global Needles Market in 2017. The growing demand for biosimilar products, the increasing incidence of chronic disease, and the expanding injectables market are the key factors contributing to the growth of this market segment.
Download PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=223979930
By product, the blood collection needles segment is expected to grow at a significant CAGR during the forecast period
Based on product, the market is segmented into suture needles, blood collection needles, ophthalmic needles, dental needles, insufflation needles, pen needles, and other needles. While the pen needles segment is expected to hold the largest share of the in 2017, it is the blood collection needles segment that is expected to grow at a significant CAGR from 2017 to 2022. Factors like the increasing number of blood donations and technological advancements in blood collection sets are driving the growth of the blood collection Needles Market.
By delivery mode, the hypodermic segment is expected to hold the largest market share in 2017
The Needles Market is segmented into hypodermic, intravenous, intramuscular, and intraperitoneal needles on the basis of delivery mode. The hypodermic needles segment is expected to account for the largest share of the Needles Market in 2017. These needles are used for injecting the drug into the subcutaneous layer; this enables the quick absorption of active compounds into the bloodstream, which is a key factor contributing to the market growth of this segment.
Speak to Analyst @ http://www.marketsandmarkets.com/speaktoanalyst.asp?id=223979930
North America dominated the market in 2016
As of 2016, North America held the largest share of the global Needles Market, followed by Europe. Its dominant share is attributed to the rising incidence of chronic diseases, initiatives by different organizations for the reduction in blood borne infections, and increasing prevalence of cardiovascular diseases.
The key players in the global Needles Market are Hamilton Company (U.S.), Medtronic plc (Ireland), Becton, Dickinson and Company (U.S.), Stryker Corporation (U.S.), B. Braun Melsungen AG (Germany), Boston Scientific Corporation (U.S.), Terumo Corporation (Japan), Novo Nordisk A/s (Denmark), Smiths Medical (U.K.), and Thermo Fisher Scientific (U.S.).
Browse Related Reports:
Pen Needles Market by Type (Standard Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Trends & Global Forecasts to 2021
Insulin Delivery Devices Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (External/Tethered, Patch), Pen Needles (Standard, Safety), Insulin Syringes) and End User (Patients/Homecare, Hospitals & Clinics) - Global Forecast to 2021
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Visit Our Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets